TD Cowen Maintains Buy Rating for Geron (GERN) While Trimming PT to $3 Ahead of Q4 Results [Yahoo! Finance]
Geron Corporation (GERN)
Last geron corporation earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
geron.com/investors
Company Research
Source: Yahoo! Finance
Bancroft reduced the firm's price target on Geron to $3 from $4 while keeping a Buy rating. This adjustment followed an update to the firm's financial model in anticipation of the company's Q4 2025 results. In Q3 2025, Geron Corporation (NASDAQ:GERN) expanded its reach by adding 150 new ordering accounts, a 15% sequential increase, and successfully initiated its first shipment of RYTELO to Germany under an early access program. Additionally, Geron's clinical pipeline remains on track, with its Phase 3 trial for relapsed/refractory myelofibrosis fully enrolled and an interim analysis expected in the second half of 2026. Despite these gains, RYTELO demand saw a 3% decline compared to the previous quarter, as growth in new patient starts was offset by discontinuations in later-line therapies. To address these headwinds, Geron implemented a restructuring and provided 2026 financial guidance projecting $220 million to $240 million in RYTELO revenue, aiming for profitability and a stren
Show less
Read more
Impact Snapshot
Event Time:
GERN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GERN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GERN alerts
High impacting Geron Corporation news events
Weekly update
A roundup of the hottest topics
GERN
News
- Geron (NASDAQ:GERN) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Geron (NASDAQ:GERN) had its "buy" rating reaffirmed by analysts at TD Cowen.MarketBeat
- Geron: Underpromise And Overdeliver Could Be The 2026 Strategy (Rating Upgrade) [Seeking Alpha]Seeking Alpha
- Geron Corporation (GERN) Eyes Profitability in 2026 amid Restructuring Drive [Yahoo! Finance]Yahoo! Finance
- Geron Corporation (GERN) Streamlines Operations, Secures Financing, Eyes 2026 Growth [Yahoo! Finance]Yahoo! Finance
GERN
Earnings
- 11/5/25 - In-Line
GERN
Sec Filings
- 1/12/26 - Form 8-K
- 1/6/26 - Form 8-K
- 1/5/26 - Form 4
- GERN's page on the SEC website